Associate Professor of Radiation Oncology, Stanford University
Radiation Oncology
Dr. Joseph C. Poen, MD
|
|
Give Review
Joseph C. Poen, MD works in the field of Radiation Oncology. He studied medicine at David Geffen School of Medicine at UCLA. David Geffen School of Medicine at UCLA is one of the top medical schools in the US. David Geffen School of Medicine at UCLA has a rank of 13 in research and a 7 in primary care He received 3 awards: "Regional Top Doctor", "CMS Meaningful Use Stage 1 Certification" and "Top MD". Joseph Poen is also published. He has 15 publications published. The lastest publication: "Chemo-radiotherapy for localized pancreatic cancer: increased dose intensity and reduced acute toxicity with concomitant radiotherapy and protracted venous infusion 5-...' He accepts all Medicare patients.
Publications
- Protracted venous infusion 5-fluorouracil with concomitant radiotherapy compared with bolus 5-fluorouracil for unresectable pancreatic Cancer.
- Preoperative chemoradiation for marginally resectable adenocarcinoma of the pancreas.
- Adjuvant chemoradiotherapy for "unfavorable" carcinoma of the ampulla of Vater: preliminary report.
- Adjuvant radiotherapy and concomitant 5-fluorouracil by protracted venous infusion for resected pancreatic Cancer.
- Fractionated stereotactic radiosurgery and preservation of hearing in patients with vestibular schwannoma: a preliminary report.
- Monoclonal antibody to HER-2/neureceptor modulates repair of radiation-induced DNA damage and enhances radiosensitivity of human breast Cancer cells overexpressing thi...
- Chemoradiotherapy in the management of localized tumors of the pancreas.
- Chemo-radiotherapy for localized pancreatic Cancer: increased dose intensity and reduced acute toxicity with concomitant radiotherapy and protracted venous infusion 5-...
- Detection of relapse in early-stage Hodgkin's disease: role of routine follow-up studies.
- High-dose therapy and autologous bone marrow transplantation for relapsed/refractory Hodgkin's disease: the impact of involved field radiotherapy on patterns of failur...
- Angiosarcoma. A report of 67 patients and a review of the literature.
- Conservation therapy for invasive lobular carcinoma of the breast.
- Phase I study of stereotactic radiosurgery in patients with locally advanced pancreatic Cancer.
- Phase II trial of preoperative 3D conformal radiotherapy, protracted venous infusion 5-fluorouracil, and weekly CPT-11, followed by surgery for ultrasound-staged T3 re...
Schools
University of California At Los Angeles
University Of California Los Angeles
Conditions Treated
- Vulvar Cancer
Doctors Specialties
- Radiation Oncology
Accepted Insurances
Awards
- Regional Top Doctor
- CMS Meaningful Use Stage 1 Certification
- Top MD
Education
-
UCLA Medical Center -
David Geffen School of Medicine at UCLA
Drug Facts
| NPI NUMBER | 1972585941 | |
| NPPES Provider LastName | POEN | |
| NPPES Provider FirstName | JOSEPH | |
| NPPES Provider ZIPCode | 949042011 | |
| NPPES Provider State | CA | |
| Specialty Description | Radiation Oncology | |
| Total Claim Count | 168.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 29.0 | |
| Percent Opioid Claims | 17.26 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1972585941 |
| Last Name Of The Provider | POEN |
| First Name Of The Provider | JOSEPH |
| View All |
Similar Doctors
|
|
Dr. Francine E. Halberg, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lloyd T. Miyawaki, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ernest W. Torigoe, MD
This Doctor is OpenDoctor Recommended.
|